Postnatal developmental changes in activation profiles of the respiratory neuronal network in the rat ventral medulla.
Two putative respiratory rhythm generators (RRGs), the para-facial respiratory group (pFRG) and the pre-Bötzinger complex (preBötC), have been identified in the neonatal rodent brainstem. To elucidate their functional roles during the neonatal period, we evaluated developmental changes of these RRGs by optical imaging using a voltage-sensitive dye. Optical signals, recorded from the ventral medulla of brainstem-spinal cord preparations of neonatal (P0-P4) rats (n = 44), were analysed by a cross correlation method. With development during the first few postnatal days, the respiratory-related activity in the pFRG reduced and shifted from a preinspiratory (P0-P1) to an inspiratory (P2-P4) pattern, whereas preBötC activity remained unchanged. The mu-opioid agonist [D-Ala(2),N-Me-Phe(4),Gly(5)-ol]-enkephalin (DAMGO) augmented preinspiratory activity in the pFRG, while the mu-opioid antagonist naloxone induced changes in spatiotemporal activation profiles that closely mimicked the developmental changes. These results are consistent with the recently proposed hypothesis by Janczewski and Feldman that the pFRG is activated to compensate for the depression of the preBötC by perinatal opiate surge. We conclude that significant reorganization of the respiratory neuronal network, characterized by a reduction of preinspiratory activity in the pFRG, occurs at P1-P2 in rats. The changes in spatiotemporal activation profiles of the pFRG neurones may reflect changes in the mode of coupling of the two respiratory rhythm generators.
Oku
Yoshitaka
Y
Department of Physiology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan. yoku@hyo-med.ac.jp
Masumiya
Haruko
H
Okada
Yasumasa
Y
D000818:Animals; D000831:Animals, Newborn; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)- / Q000494:pharmacology; D008526:Medulla Oblongata / Q000187:drug effects / Q000254:growth & development* / Q000502:physiology*; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D009415:Nerve Net / Q000187:drug effects / Q000254:growth & development* / Q000502:physiology*; D018377:Neurotransmitter Agents / Q000494:pharmacology; D010507:Periodicity; D051381:Rats; D015656:Respiratory Mechanics / Q000187:drug effects / Q000502:physiology*; D012143:Respiratory Physiological Phenomena
D009292:Narcotic Antagonists; D018377:Neurotransmitter Agents; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; D009270:Naloxone